Rosuvastatin and Evolocumab for Coronary Artery Disease

NCT05984953 · clinicaltrials.gov ↗

COMPLETED

Status

195

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: statin
DRUG: evolocumab

Sponsor

Icahn School of Medicine at Mount Sinai